Recently published research out of South Korea has presented a new method of differentiating mesenchymal stem cells [MSCs] into liver cells for autologous use in regenerative medicine. Geneticists found that the overexpression of two genes within MSCs, oct4 and sox2, resulted in the stem cells converting into fully functional hepatocytes, or liver cells, capable of producing urea and storing glycogen.
Topics: hepatocytes, liver cells, regenerate organs, Stemcells, stem cell differentiation, Liver disease, research, StemSave, mesenchymal stem cells, autologous stem cells, stem cells, biology, adult stem cells
Bioengineers from Brigham Women’s Hospital have identified several microscopic compounds that can vastly improve the efficiency of stem cell clinical applications. The molecules, when attached to the surface of mesenchymal stem cells [MSCs], allow the cells to home in on target blood vessels to travel directly to the site of damage or disease and stay there long enough to treat the problem.